Health IT

Health Union's latest awards aren't just for recognition. They're building a new strategic infrastructure for patient influence, complete with certifications.

With a fresh $31M, Advanced NanoTherapies is advancing a first-of-its-kind dual-drug nanoparticle balloon, a technology poised to disrupt the market.

Beyond the headlines of EHA 2026, Eli Lilly's latest data and acquisitions reveal a bold strategy to conquer the hematology market. It's a three-pronged assault.

Medscape's new AI symposium aims to guide hematologists through an ethical revolution, promising to enhance, not replace, clinical expertise. Is this the future?

With an $18M Series A, Novellia is flipping the script on real-world data, empowering patients to solve a decades-old, multi-billion-dollar R&D bottleneck.

The Dallas Cowboys are using a new device to build muscle. It’s part of a high-stakes trend where technology is redefining athlete recovery and longevity.

With real estate worth more than its stock and ambitious R&D plans, Cosmos Health claims it's undervalued. But is an unusual crypto strategy clouding the picture?

Amidst soaring HIV rates and public health emergencies, a new campaign shows why top-down solutions fail and community-led resilience is the only way forward.

A breakthrough in cardiac fibrosis treatment reveals more than a new drug; it signals a systemic shift. How AI and human 'organoids' are making animal models obsolete.

While competitors build complex apps, Maxwell TEC is winning the home care market with simple SMS. Their milestone is a strategic signal for patient engagement.

A renowned patient safety expert returns to helm Alberta's quality watchdog, bringing a 'Just Culture' philosophy to a health system in crisis and transition.

A new report reveals the staggering financial and human cost of treatment-resistant depression, highlighting massive gaps in patient and caregiver support.

A Tulsa jury found a doctor negligent, awarding $15M to a girl left with severe brain damage after a missed diagnosis of bacterial meningitis as an infant.

Groundbreaking research on new drug classes, the gut-brain axis, and personalized medicine will be unveiled at the upcoming American Headache Society meeting.

A fivefold increase in one year, THINK Surgical’s miniature robot is reshaping orthopedics with its unique open platform and powerful industry partnerships.

Therini Bio's novel drug THN391 enters trials, targeting inflammation in diabetic eye disease, while a next-gen combo therapy aims to redefine care.

Facing a crisis of consumer trust, the food industry is uniting to fight dangerous myths and rebuild confidence in the science of what we eat.

With backing from GV and Dexcom, Signos is using AI and OTC glucose monitors to offer a new path for sustainable weight management beyond GLP-1 drugs.

The government is set to announce a new wave of research awards, part of a $1.7B strategy to attract top international scientists and fuel innovation.

Supergoop! founder Holly Thaggard's new venture, WaterOuai!, tackles chemical exposure with an innovative can designed for truly clean hydration.